SWP1 Antibody

Shipped with Ice Packs
In Stock

Description

Overview of SP1 Antibody

SP1 Antibody targets Specificity Protein 1 (SP1), a transcription factor that binds GC-rich DNA motifs to regulate genes involved in cell proliferation, apoptosis, and differentiation . It is widely used in research and diagnostics, particularly in cancer studies .

Diagnostic and Prognostic Utility in Breast Cancer

  • ER Detection: SP1 antibody (clone SP1) demonstrates superior sensitivity compared to older clones like 1D5 for estrogen receptor (ER) detection in breast cancer .

    • Clinical Outcomes: SP1-positive/1D5-negative cases (8% of patients) showed survival outcomes comparable to double-positive cases, suggesting SP1 identifies ER-positive patients missed by 1D5 .

ParameterSP1 Antibody1D5 Antibody
Sensitivity (vs. biochemical assay)92%84%
Positive Predictive Value98%92%
ER Detection Rate69.5%63.1%

Tumor Prognosis and Metastasis

  • Meta-Analysis: Elevated SP1 expression correlates with:

    • Lymph node metastasis (OR = 0.42, p < 0.05)

    • Advanced TNM stage (OR = 0.34, p < 0.05)

    • Poor survival in hepatocellular, pancreatic, and gastric cancers (HR = 1.95) .

Technical Performance

  • Immunohistochemistry (IHC):

    • Optimal dilution: 1:500–1:5000 .

    • Nuclear staining pattern in formalin-fixed tissues .

  • Western Blot: Detects SP1 at ~81–90 kDa .

Comparative Studies with Other Antibodies

  • EP1 vs. SP1: EP1 (another ERα antibody) showed 96.7% agreement with SP1 in breast cancer cohorts, but SP1 had stronger signal-to-noise ratios .

  • SP1 vs. 1D5: SP1 identified 6.4% more ER-positive cases in tissue microarrays, with better prognostic stratification .

Mechanistic Insights

SP1 regulates cancer-associated genes like:

  • VEGF (angiogenesis) .

  • MMP-2/MMP-9 (invasion in lung cancer) .

  • IGF1R (proliferation in breast cancer) .

Limitations and Controversies

  • Inter-Laboratory Variability: While SP1 is robust, IHC protocols require standardization to minimize variability .

  • Cross-Reactivity: No cross-reactivity with ERβ confirmed .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SWP1 antibody; YMR149W antibody; YM9375.19 antibody; Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit SWP1 antibody; Oligosaccharyl transferase subunit SWP1 antibody; Oligosaccharyl transferase subunit delta antibody
Target Names
SWP1
Uniprot No.

Target Background

Function
SWP1 is a subunit of the oligosaccharyl transferase (OST) complex. This complex catalyzes the initial transfer of a specific glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains. This process, known as protein N-glycosylation, is the first step in N-linked glycosylation. N-glycosylation occurs cotranslationally, and the OST complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). All subunits of the OST complex are essential for maximal enzyme activity.
Database Links

KEGG: sce:YMR149W

STRING: 4932.YMR149W

Protein Families
SWP1 family
Subcellular Location
Endoplasmic reticulum membrane; Multi-pass membrane protein.

Q&A

What is SWP1 protein and why are antibodies against it important for research?

SWP1 is a phytoplasma effector protein that has been demonstrated to induce witches' broom symptoms in plants, a condition characterized by excessive branching and altered plant development. This protein contains specific domains including a coiled-coil (CC) domain and a nuclear localization signal (NLS) that are critical to its function in pathogenesis . Antibodies against SWP1 serve as essential tools for detecting and studying this protein in infected plant tissues, enabling researchers to track protein expression, localization, and accumulation during infection processes. The significance of these antibodies extends to analyzing how SWP1 interacts with host proteins, particularly with plant transcription factors such as those in the TCP family, which are targeted during infection . SWP1 antibodies allow for precise quantification of protein levels in transgenic systems and provide crucial insights into the molecular mechanisms underlying phytoplasma pathogenicity and symptom development in host plants.

How do researchers distinguish between specific and non-specific binding when using SWP1 antibodies?

Distinguishing between specific and non-specific binding is a critical consideration when using SWP1 antibodies in experimental procedures. Researchers typically employ multiple control approaches similar to those used with other antibodies such as SP1. These include performing parallel experiments with samples known to be negative for SWP1 expression to establish background signal levels and using isotype control antibodies to identify non-specific binding patterns . The inclusion of transgenic plant lines expressing SWP1 alongside wild-type controls provides an excellent system for antibody validation, as demonstrated in the SWP1 expression studies where protein detection was confirmed by western blot analysis . Signal-to-noise ratio assessment is particularly important, as seen in SP1 antibody evaluations where stronger signal-to-noise ratios directly correlated with improved detection sensitivity . Additionally, researchers often perform pre-absorption tests with purified recombinant SWP1 protein to confirm antibody specificity, and employ knockout or silenced plant lines as negative controls to verify that detected signals disappear in the absence of the target protein.

What experimental applications are SWP1 antibodies most commonly used for?

SWP1 antibodies have become instrumental in several experimental applications within plant pathology and molecular biology research. Western blot analysis represents the primary application, allowing researchers to detect and quantify SWP1 protein expression in both naturally infected plant tissues and transgenic systems, as evidenced in studies examining SWP1 expression in Arabidopsis lines . Immunoprecipitation (IP) assays utilize SWP1 antibodies to isolate the protein along with its interacting partners, enabling the investigation of molecular interactions between SWP1 and host proteins such as TCP transcription factors . Immunofluorescence microscopy applications permit the visualization of SWP1 localization within plant cells, providing insights into its nuclear accumulation facilitated by the NLS domain, which is critical for its pathogenic function . Additionally, chromatin immunoprecipitation (ChIP) experiments employ SWP1 antibodies to examine potential associations with DNA, helping researchers understand if SWP1 influences gene expression through direct or indirect interactions with chromatin structures. Enzyme-linked immunosorbent assays (ELISA) utilizing SWP1 antibodies allow for high-throughput screening of infected plant samples in field studies and epidemiological research.

How can SWP1 antibodies be employed to investigate the interaction between SWP1 and TCP transcription factors?

The interaction between SWP1 and TCP transcription factors represents a critical aspect of phytoplasma pathogenesis that can be effectively studied using SWP1 antibodies through several sophisticated approaches. Co-immunoprecipitation (Co-IP) experiments using SWP1 antibodies can capture protein complexes containing both SWP1 and TCP transcription factors, providing direct evidence of their physical interaction in plant cells . This technique can be complemented with reverse Co-IP using TCP-specific antibodies to confirm binding specificity from both protein perspectives. Proximity ligation assays (PLA) utilizing SWP1 antibodies in combination with TCP antibodies enable researchers to visualize the spatial proximity of these proteins within plant cell nuclei, generating fluorescent signals only when the proteins are within 40nm of each other. Chromatin immunoprecipitation followed by sequencing (ChIP-seq) with SWP1 antibodies can map genome-wide binding sites, potentially identifying regions where SWP1 associates with DNA through interaction with TCP transcription factors, similar to methodologies employed with SP1 antibodies in other research contexts . Additionally, researchers can utilize SWP1 antibodies in protein immunodepletion experiments to selectively remove SWP1 from protein extracts and observe the consequent effects on TCP binding to target DNA sequences, thereby establishing functional relationships between these proteins.

What methodological approaches can maximize detection sensitivity when using SWP1 antibodies in plants with low expression levels?

Maximizing detection sensitivity for SWP1 in plant samples with low expression levels requires sophisticated methodological refinements similar to those employed with other challenging antibody applications. Signal amplification systems such as tyramide signal amplification (TSA) can dramatically enhance detection sensitivity by depositing multiple fluorophores at antibody binding sites, increasing signal strength by orders of magnitude. Researchers should consider employing modern super-resolution microscopy techniques like structured illumination microscopy (SIM) or stochastic optical reconstruction microscopy (STORM) when using fluorescently-labeled SWP1 antibodies, allowing visualization of protein localization beyond the diffraction limit of light. The optimization of antigen retrieval protocols is critical for fixed plant tissues, with careful titration of pH, temperature, and buffer compositions to maximize epitope accessibility without compromising tissue integrity . For western blot applications, extended exposure times combined with highly sensitive chemiluminescent substrates can enhance detection capability, though researchers must carefully balance signal enhancement against potential background increase . Additionally, employing antibody concentration techniques for plant extracts prior to immunoassays, such as immunoaffinity purification or protein precipitation, can effectively increase the target protein concentration relative to total protein content, thereby improving detection probability in samples with naturally low SWP1 expression.

How can SWP1 antibodies be utilized to investigate post-translational modifications of the SWP1 protein during infection?

Investigating post-translational modifications (PTMs) of SWP1 during infection requires sophisticated application of antibody-based techniques combined with advanced analytical methods. Researchers can develop and utilize modification-specific SWP1 antibodies that selectively recognize phosphorylated, ubiquitinated, or otherwise modified forms of the protein, similar to approaches used with other proteins like SP1, where specific forms can be discriminated . Two-dimensional gel electrophoresis followed by western blotting with SWP1 antibodies allows separation of protein isoforms with different PTMs, creating a "modification map" of SWP1 during various infection stages. Immunoprecipitation with standard SWP1 antibodies followed by mass spectrometry analysis enables comprehensive identification of PTMs across the entire protein sequence, revealing modification sites that may regulate SWP1's interaction with TCP transcription factors or influence its nuclear localization . Time-course experiments using SWP1 antibodies to track protein modifications throughout infection progression can establish temporal relationships between specific PTMs and symptom development, particularly the witches' broom phenotype observed in transgenic plants . Additionally, comparative analyses between wild-type SWP1 and domain-deletion mutants (such as SWP1 ΔNLSCC and SWP1 ΔCC) can reveal how specific protein domains influence the acquisition of PTMs, providing deeper insights into structure-function relationships.

What controls should be included when validating a new SWP1 antibody for research applications?

Comprehensive validation of a new SWP1 antibody requires a systematic approach with multiple control experiments to ensure specificity and reliability. Researchers should include SWP1-expressing transgenic plants alongside wild-type controls to confirm that the antibody specifically detects the target protein when present and shows minimal background when absent, similar to validation approaches used with SP1 antibodies . Blocking peptide experiments, where the antibody is pre-incubated with purified recombinant SWP1 protein before application to samples, should demonstrate signal reduction or elimination if the antibody is truly specific. Western blot analysis using known quantities of recombinant SWP1 protein allows for the generation of standard curves to assess antibody sensitivity and linear detection range, critical parameters for quantitative applications . Cross-reactivity testing against related proteins, particularly other phytoplasma effectors that may share structural similarities with SWP1, helps confirm that the antibody discriminates between potential homologs. Researchers should also perform parallel experiments with multiple independent antibody lots to verify reproducibility, and ideally compare results with alternative detection methods such as fluorescent protein tagging or mass spectrometry to validate findings across methodological approaches .

How should researchers design experiments to differentiate between full-length SWP1 and its deletion mutants using antibodies?

Designing experiments to differentiate between full-length SWP1 and its deletion mutants requires careful consideration of epitope location and detection strategies. Researchers should select or develop antibodies that target conserved regions present in all constructs to enable comparative detection, while also considering epitope-specific antibodies that recognize domains unique to certain variants . Western blot analysis with high-resolution gel systems capable of resolving small molecular weight differences can distinguish between full-length SWP1 and deletion mutants such as SWP1 ΔNLSCC and SWP1 ΔCC based on migration patterns . Immunoprecipitation followed by mass spectrometry provides definitive identification of protein variants by generating peptide fingerprints unique to each construct, enabling distinction even when size differences are minimal. For immunofluorescence applications, co-localization studies using antibodies against subcellular compartment markers can differentiate between variants with and without the NLS domain based on their nuclear versus cytoplasmic distribution patterns . Additionally, researchers should consider developing competitive ELISA assays where antibodies with known epitope specificity compete for binding with pan-SWP1 antibodies, allowing quantitative assessment of different protein variants within complex samples.

What are the key considerations for optimizing immunoprecipitation protocols when using SWP1 antibodies?

Optimizing immunoprecipitation protocols with SWP1 antibodies requires attention to several critical parameters that influence efficiency and specificity. Buffer composition represents a primary consideration, with researchers needing to balance extraction efficiency against preserving protein-protein interactions; typically, non-ionic detergents like NP-40 or Triton X-100 at concentrations between 0.1-1% provide effective solubilization while maintaining most interactions . Antibody concentration and incubation conditions significantly impact immunoprecipitation success, with optimal ratios typically determined through titration experiments; commercial systems generally recommend antibody dilutions between 1:200 (as seen with SP1 antibodies) to 1:50 depending on antibody affinity and target abundance . The choice between protein A/G beads, magnetic beads, or direct antibody conjugation to solid supports should be guided by the antibody isotype and experimental requirements, with magnetic systems often providing superior recovery for nuclear proteins like SWP1 . Pre-clearing steps using control beads or non-specific antibodies of the same species can dramatically reduce non-specific binding, particularly important when working with plant extracts that contain numerous proteins with sticky properties. Temperature and timing parameters require careful optimization, with antibody-antigen binding typically performed at 4°C overnight to maximize specific interactions while minimizing protein degradation and non-specific associations.

What strategies can overcome cross-reactivity challenges between SWP1 antibodies and other plant proteins?

Overcoming cross-reactivity challenges between SWP1 antibodies and plant proteins requires sophisticated approaches to enhance specificity and reduce false positive signals. Antibody pre-absorption with plant tissue extracts from uninfected or non-transgenic plants can effectively remove antibodies that recognize endogenous plant proteins, leaving primarily those specific to SWP1, similar to approaches used to improve specificity in other antibody applications . The implementation of dual-labeling strategies, where samples are probed with two different SWP1 antibodies recognizing distinct epitopes, can dramatically increase detection confidence, as signals resulting from true SWP1 presence will show colocalization of both antibodies. Researchers should consider employing competitive assays with recombinant SWP1 protein to confirm signal specificity, where the addition of increasing amounts of purified protein should proportionally reduce antibody binding to the target in samples if the signal is genuine . Epitope mapping and antibody engineering approaches can be utilized to develop next-generation SWP1 antibodies with enhanced specificity, focusing on unique regions of the protein with minimal homology to plant proteomes. Additionally, complementary non-antibody detection methods such as aptamer-based recognition or MS-based targeted proteomics can provide orthogonal validation of SWP1 antibody specificity across different plant species and tissues.

How can researchers adapt SWP1 antibody protocols when working with different plant species that may have varying tissue compositions?

Adapting SWP1 antibody protocols for different plant species requires systematic optimization accounting for tissue-specific characteristics and species-specific biochemical variations. Researchers should implement customized tissue preparation methods that address the unique challenges of each plant species, such as adjusting fixation parameters (time, temperature, and fixative composition) based on tissue density, water content, and cellular architecture . Extraction buffer modifications represent a critical adaptation point, with researchers needing to adjust pH, ionic strength, and detergent concentrations based on the particular biochemical properties of each plant species; for instance, tissues with high phenolic content may require higher concentrations of reducing agents and PVP/PVPP . Antigen retrieval protocols should be empirically optimized for each new plant species, with systematic testing of different retrieval buffers, temperatures, and incubation times to maximize epitope accessibility while preserving tissue integrity. The antibody concentration and incubation parameters often require species-specific adjustments, with some plant tissues necessitating higher antibody concentrations or longer incubation periods to achieve adequate penetration and binding, while others may show optimal results with more dilute antibody solutions applied for shorter durations . Additionally, researchers should consider implementing species-specific blocking strategies, potentially incorporating extracts from the plant species being studied into blocking solutions to competitively inhibit non-specific binding sites unique to that species.

How should researchers quantitatively analyze western blot data when comparing SWP1 expression levels across different experimental conditions?

Quantitative analysis of western blot data for SWP1 expression requires rigorous methodological approaches to ensure accuracy and reproducibility across experimental conditions. Researchers should implement proper normalization strategies using housekeeping proteins appropriate for the specific experimental conditions, recognizing that traditional references like actin or tubulin may themselves be affected by phytoplasma infection, necessitating validation of multiple candidates for each experimental system . Densitometric analysis should be performed using specialized software with defined parameters for background subtraction and band identification, with researchers analyzing bands within the linear detection range of the imaging system, typically established through standard curves generated with purified recombinant SWP1 . Technical replicates (multiple lanes of the same sample) and biological replicates (independent experimental preparations) are essential for statistical validity, with a minimum of three biological replicates generally required for publication-quality data. Researchers should employ appropriate statistical analyses based on the experimental design, including ANOVA for multi-condition comparisons or t-tests for pairwise comparisons, while reporting effect sizes alongside p-values to convey biological significance . Additionally, the implementation of quantitative fluorescent western blotting techniques using fluorescently-labeled secondary antibodies rather than chemiluminescence can provide superior linearity and reproducibility for SWP1 quantification, similar to the quantitative immunofluorescent approaches described for other protein targets .

What statistical approaches are most appropriate for analyzing immunofluorescence data from SWP1 antibody experiments?

Statistical analysis of immunofluorescence data from SWP1 antibody experiments requires specialized approaches that address the complex, multi-dimensional nature of these datasets. Researchers should implement proper image segmentation methods to accurately define cellular compartments (nucleus, cytoplasm, membrane) for subcellular localization analysis of SWP1, using automated algorithms to eliminate selection bias that can occur with manual region-of-interest definition . Colocalization analysis between SWP1 and cellular markers or interacting proteins should utilize established quantitative metrics such as Pearson's correlation coefficient, Manders' overlap coefficient, or object-based colocalization methods, rather than relying solely on visual assessment of color overlap . When comparing fluorescence intensities across different experimental conditions, researchers should employ normalization strategies to account for variations in staining efficiency, microscope settings, and detector sensitivity, potentially using internal reference standards within each sample. Statistical comparisons between experimental groups should account for the nested nature of immunofluorescence data (multiple cells within fields, multiple fields within samples), typically requiring mixed-effects models rather than simple t-tests or ANOVA . Additionally, researchers should consider employing machine learning approaches for analyzing complex immunofluorescence patterns, particularly when studying the relationship between SWP1 localization and phenotypic outcomes like witches' broom symptoms in plant tissues with heterogeneous infection levels .

How can researchers interpret conflicting results between different detection methods when studying SWP1 expression and localization?

Interpreting conflicting results between different SWP1 detection methods requires a systematic approach that considers the inherent strengths and limitations of each technique. Researchers should thoroughly evaluate the sensitivity thresholds of each method, recognizing that techniques like western blotting and immunoprecipitation may have different detection limits, similar to the variations observed between SP1 antibodies where some methods showed 8-16.9% discrepancy rates despite targeting the same protein . The spatial resolution of detection methods varies significantly, with immunofluorescence providing subcellular localization information that may clarify seemingly contradictory bulk measurements from biochemical assays, particularly important when studying proteins like SWP1 that shuttle between cellular compartments . Researchers must consider potential artifacts introduced by sample preparation, as different fixation and extraction protocols can selectively preserve or disrupt specific protein populations or conformations, potentially explaining discrepancies between methods. When conflicts arise, orthogonal validation using independent approaches becomes crucial, such as complementing antibody-based detection with fluorescent protein fusions or mass spectrometry, as demonstrated in studies of SWP1 mutants . Additionally, researchers should examine time-dependent dynamics, as conflicting results may reflect genuine biological differences in SWP1 expression or localization at different stages of infection or plant development rather than methodological inconsistencies.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.